fosinopril has been researched along with endothelin-1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azizi, M; Bissery, A; Guyene, TT; Labatide-Alanore, A; Lamarre-Cliche, M; Ménard, J | 1 |
Bartels, T; Dominiak, P; Häuser, W; Raasch, W; Rütten, H; Schwartz, C | 1 |
1 trial(s) available for fosinopril and endothelin-1
Article | Year |
---|---|
Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelins; Fosinopril; Humans; Male; Neprilysin; Oligopeptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Protein Precursors; Pyridines; Renin; Sodium, Dietary; Thiazepines; Time Factors | 2002 |
1 other study(ies) available for fosinopril and endothelin-1
Article | Year |
---|---|
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Captopril; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Fosinopril; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred SHR | 2002 |